FDA’s Strategic Roadmap to Phase Out Animal Testing: How Computational Models Are Revolutionizing Drug Development
The Paradigm Shift in Preclinical Testing The FDA has announced a strategic shift away from animal testing, citing that over 90% of drugs successful in animals fail FDA approval due to human safety and efficacy issues—especially in cancer, Alzheimer’s, and … Read More